Esther (E) van Wezel
- Experimental Immunohematology
- Research interests
- Improvement of risk stratification and treatment allocation for all stages neuroblastoma patients by real time quantitative (RQ)- PCR minimal residual disease (MRD) testing, by using a panel of RQ-PCR targets.
RQ- PCR based detection of minimal residual disease
2011-present PhD studen at Dept of Experimental Immunohematology, Sanquin Research, Amsterdam 2008 (Feb-July) Research project at Dept of Molecular Medicine, Institute of Child Health, London, UK 2004-2011 Medicine, University of Amsterdam
- Sanquin publications
Last edited on: 23 September 2013Back to the overview page